PLoS ONE (Jan 2021)

Enhanced virulence of Plasmodium falciparum in blood of diabetic patients.

  • Jun-Hong Ch'ng,
  • Kirsten Moll,
  • Katja Wyss,
  • Ulf Hammar,
  • Mikael Rydén,
  • Olle Kämpe,
  • Anna Färnert,
  • Mats Wahlgren

DOI
https://doi.org/10.1371/journal.pone.0249666
Journal volume & issue
Vol. 16, no. 6
p. e0249666

Abstract

Read online

Rising prevalence of diabetes in sub-Saharan Africa, coupled with continued malaria transmission, has resulted more patients dealing with both communicable and non-communicable diseases. We previously reported that travelers with type 2 diabetes mellitus (T2DM) infected with Plasmodium falciparum were three times more likely to develop severe malaria than non-diabetics. Here we explore the biological basis for this by testing blood from uninfected subjects with type 1 and type 2 diabetes, ex vivo, for their effects on parasite growth and rosetting (binding of infected erythrocytes to uninfected erythrocytes). Rosetting was associated with type 2 diabetes, blood glucose and erythrocyte sedimentation rate (ESR), while parasite growth was positively associated with blood glucose, glycated hemoglobin (HbA1c), body mass index (BMI), fibrinogen and triglycerides. This study establishes a link between diabetes and malaria virulence assays, potentially explaining the protective effect of good glycemic control against severe malaria in subjects with diabetes.